PTK2 and mantle cell lymphoma: FAK was upregulated/activated in MCL cells in a CXCL12-dependent manner, FAK inhibition and downmodulation decreased the migration capabilities of MCL cells, and FAK inhibition was capable of overcoming Ibrutinib-resistance in MCL